Výsledky vyhledávání - Lawrence E. Morris
- Zobrazuji výsledky 1 - 17 z 17
-
1
Calcineurin Inhibitor–Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peripheral Blood... Autor Scott R. Solomon, Melissa Sanacore, Xu Zhang, Stacey Brown, Kent Holland, Lawrence E. Morris, Asad Bashey
Vydáno 2014Artigo -
2
Factors Predicting Graft-versus-Host Disease–Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center Autor Melhem Solh, Xu Zhang, Katelin Connor, Stacey Brown, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, Asad Bashey
Vydáno 2016Artigo -
3
Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventi... Autor Scott R. Solomon, Connie A. Sizemore, Melissa Sanacore, Xu Zhang, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Asad Bashey
Vydáno 2012Artigo -
4
Total Body Irradiation–Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Match... Autor Scott R. Solomon, Connie A. Sizemore, Melissa Sanacore, Xu Zhang, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Asad Bashey
Vydáno 2015Artigo -
5
T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of... Autor Asad Bashey, Xu Zhang, Connie A. Sizemore, Karen Manion, Stacey Brown, H. Kent Holland, Lawrence E. Morris, Scott R. Solomon
Vydáno 2013Artigo -
6
Comparison of Outcomes of Hematopoietic Cell Transplants from T-Replete Haploidentical Donors Using Post-Transplantation Cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -D... Autor Asad Bashey, Xu Zhang, Katelin C Jackson, Stacey Brown, Michelle Ridgeway, Melhem Solh, Lawrence E. Morris, H. Kent Holland, Scott R. Solomon
Vydáno 2015Artigo -
7
Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patient... Autor Zain Bashey, Xu Zhang, Stacey Brown, Katelin C Jackson, Lawrence E. Morris, H. Kent Holland, Asad Bashey, Scott R. Solomon, Melhem Solh
Vydáno 2018Artigo -
8
A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fluda... Autor Judith E. Karp, Francis J. Giles, Ivana Gojo, Lawrence E. Morris, Jacqueline M. Greer, Bonny Johnson, Mya Thein, Mario Sznol, Jennifer A. Low
Vydáno 2007Artigo -
9
Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables Autor Scott R. Solomon, Michael T. Aubrey, Xu Zhang, Allison Piluso, Brian M. Freed, Stacey Brown, Katelin C Jackson, Lawrence E. Morris, H. Kent Holland, Melhem Solh, Asad Bashey
Vydáno 2018Artigo -
10
Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia Autor Steven D. Gore, Ivana Gojo, Mikkael A. Sekeres, Lawrence E. Morris, Marcel P. Devetten, Katarzyna Jamieson, Robert L. Redner, R.J. Arceci, Ibitayo Owoeye, Tianna Dauses, Esther Schachter-Tokarz, Robert E. Gallagher
Vydáno 2010Artigo -
11
CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation Autor Asad Bashey, Bridget Medina, Sue Corringham, Mildred Pasek, Ewa Carrier, Linda Vrooman, Israel Lowy, Scott R. Solomon, Lawrence E. Morris, H. Kent Holland, James R. Mason, Edwin P. Alyea, Robert J. Soiffer, Edward D. Ball
Vydáno 2008Artigo -
12
A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia Autor Jeffrey E. Lancet, Ivana Gojo, Jason Gotlib, Eric J. Feldman, Jacqueline M. Greer, Jane L. Liesveld, Laura M. Bruzek, Lawrence E. Morris, Youn Park, Alex A. Adjei, Scott H. Kaufmann, Elizabeth Garrett‐Mayer, Peter L. Greenberg, James R. Wright, Judith E. Karp
Vydáno 2006Artigo -
13
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial Autor Ephraim J. Fuchs, Paul V. O’Donnell, Mary Eapen, Brent R. Logan, Joseph H. Antin, Peter Dawson, Steven M. Devine, Mary M. Horowitz, Mitchell E. Horwitz, Chatchada Karanes, Eric Leifer, John Magenau, Joseph P. McGuirk, Lawrence E. Morris, Andrew R. Rezvani, Richard J. Jones, Claudio G. Brunstein
Vydáno 2020Artigo -
14
Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome Autor Yvette L. Kasamon, Leo Luznik, Mary S. Leffell, Jeanne Kowalski, Hua-Ling Tsai, Javier Bolaños‐Meade, Lawrence E. Morris, Pamela Crilley, Paul V. O’Donnell, Nancy Rossiter, Carol Ann Huff, Robert A. Brodsky, William Matsui, Lode J. Swinnen, Ivan Borrello, Jonathan D. Powell, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs
Vydáno 2009Artigo -
15
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial Autor Joseph Alvarnas, Jennifer Le Rademacher, Yanli Wang, Richard F. Little, Görgün Akpek, Ernesto Ayala, Steven M. Devine, Robert A. Baiocchi, Gerard Lozanski, Lawrence D. Kaplan, Ariela Noy, Uday Popat, Jack W. Hsu, Lawrence E. Morris, Jason Thompson, Mary M. Horowitz, Adam Mendizabal, Alexandra M. Levine, Amrita Krishnan, Stephen J. Forman, Willis H. Navarro, Richard F. Ambinder
Vydáno 2016Artigo -
16
The Composite Health Risk Assessment Model (CHARM) to Predict 1-Year Non-Relapse Mortality (NRM) Among Older Recipients of Allogeneic Transplantation: A Prospective BMT-CTN Study 1... Autor Andrew Artz, Brent R. Logan, Wael Saber, Nancy L. Geller, Anna Bellach, Jianqun Kou, William A. Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Tammy A. Schuler, Asmita Mishra, Joseph P. Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R. McCurdy, Lawrence E. Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Mohamed L. Sorror
Vydáno 2023Artigo -
17
Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704 Autor Mohamed L. Sorror, Wael Saber, Brent R. Logan, Nancy L. Geller, Anna Bellach, Jianqun Kou, William A. Wood, John M. McCarty, Thomas G. Knight, Lyndsey Runaas, Laura Johnston, Jeremy Walston, Ryotaro Nakamura, Louise Jarrett, Asmita Mishra, Joseph P. Uberti, Parastoo B. Dahi, Jennifer N. Saultz, Shannon R. McCurdy, Lawrence E. Morris, Philip Imus, William J. Hogan, Kalyan Nadiminti, Vijaya Raj Bhatt, Rebecca L. Olin, Joseph E. Maakaron, Ronald Sobecks, Sarah Wall, Deborah Mattila, Bailey Protz, Steven M. Devine, Mary M. Horowitz, Andrew Artz
Vydáno 2025Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Transplantation
Chemotherapy
Gastroenterology
Cyclophosphamide
Surgery
Hematopoietic stem cell transplantation
Immunology
Graft-versus-host disease
Oncology
Biology
Cumulative incidence
Antigen
Genetics
Human leukocyte antigen
Biochemistry
Gene
Progressive disease
Stem cell
Adverse effect
Astrobiology
Busulfan
Cancer
Chemistry
Clinical trial
Confidence interval
Cytarabine
Fludarabine
Haematopoiesis